rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lee Heeson

EVP, Head of Incyte Intl

Company insider

Files Form 4 as: EVP, Head of Incyte Intl, Incyte.

In numbers

Trades disclosed
14
Buys
0
Sells
1
Bought
$0
Sold
$289K
Companies
1
Companies where not an officer
0
First trade
1 Oct 2024
Last trade
1 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
INCY IncyteOfficer · Life-science tools · last 1 Oct 20260 buys · 1 sell

Activity over time

1 Nov 2025 – 1 Oct 2026
10Nov 25Feb 26May 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 5 Oct 2026INCY IncyteLife-science toolsSEC FORM 4 Code F$54K463 at $117.14filing
23 Jul 2026filed 27 Jul 2026INCY Incyteoption or derivative · Life-science toolsSEC FORM 4 Code A—15,423 at $0.00filing
23 Jul 2026filed 27 Jul 2026INCY Incyteoption or derivative · Life-science toolsSEC FORM 4 Code A—13,498 at $0.00filing
23 Jul 2026filed 27 Jul 2026INCY Incyteoption or derivative · Life-science toolsSEC FORM 4 Code A—15,423 at $0.00filing
23 Jul 2026filed 27 Jul 2026INCY Incyteoption or derivative · Life-science toolsSEC FORM 4 Code A—13,498 at $0.00filing
2 Feb 2026filed 4 Feb 2026INCY IncyteLife-science toolsSEC FORM 4 Code F$11K111 at $102.67filing
2 Feb 2026filed 4 Feb 2026INCY IncyteLife-science toolsSEC FORM 4 Code F$11K111 at $102.67filing
16 Jan 2026filed 21 Jan 2026INCY IncyteLife-science toolsSEC FORM 4 Code A—8,911 at $0.00filing
16 Jan 2026filed 21 Jan 2026INCY IncyteLife-science toolsSEC FORM 4 Code A—8,911 at $0.00filing
3 Nov 2025filed 5 Nov 2025INCY IncyteLife-science toolsSEC FORM 4 Sold$289K3,074 at $94.02filing
1 Oct 2025filed 3 Oct 2025INCY IncyteLife-science toolsSEC FORM 4 Code F$40K463 at $86.70filing
15 Jul 2025filed 17 Jul 2025INCY Incyteoption or derivative · Life-science toolsSEC FORM 4 Code A—6,577 at $0.00filing
31 Jan 2025filed 3 Feb 2025INCY IncyteLife-science toolsSEC FORM 4 Code A—6,331 at $0.00filing
1 Oct 2024filed 3 Oct 2024INCY IncyteLife-science toolsSEC FORM 4 Code A—26,447 at $0.00filing

News

Incyte (NASDAQ:INCY) & Agios Pharmaceuticals (NASDAQ:AGIO) Critical ContrastINCY · dailypolitical.com · 6 Oct 2026

0 headlines in the last 90 days name Lee Heeson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Pablo J. CagnoniPresident, Global Head of R&D · President, Global Head of R&D at Incyte, filing Form 4 there in the last year
Edmund HarriganDirector · Director at Incyte, filing Form 4 there in the last year
Paul J. ClancyDirector · Director at Incyte, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Director and 10% owner at Incyte, filing Form 4 there in the last year
David H. GardnerEVP, Chief Strategy Officer · EVP, Chief Strategy Officer at Incyte, filing Form 4 there in the last year
Patrick A. MayesEVP & Chief Scientific Officer · Also traded INCY in the last 90 days